Gene-Disorder Association · Article
Gene
CHRNA4 Cholinergic Receptor Nicotinic Alpha 4 Subunit
×
First reported
2004
Supporting publications
5
Manually curated Approved treatment annotated
Association Review
In brief The association between CHRNA4 (Cholinergic Receptor Nicotinic Alpha 4 Subunit) and Tobacco Addiction is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording a known molecular basis and a susceptibility locus.
Sources
2
Clinical variants
55
Symptoms
1
Compounds
2
Trials
126 of 351 via CHRNA4 compounds
Publications
5
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access 02
Provenance
Evidence and sources 2 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access 2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access 04
Tobacco Addiction
The disorder 10 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access 05
Phenotype
Clinical features 1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access 06
ClinVar and variant evidence
Genetic basis 55 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access 07
Interventions
Therapeutics 2 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access 08
Human studies
Clinical trials 351 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access 5 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access 10
Provenance
References & sources 16 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access 
